MAPT and frontotemporal dementia: In this study, we found that β-arrestin1 is significantly increased in frontotemporal lobar degeneration-tau (FTLD-tau) patients, a degenerative condition defined by tauopathy in the absence of Aβ deposits, and elevated β-arrestin1 promotes tau accumulation and tauopathy in vitro and in vivo by two distinct mechanisms.